Huntington National Bank’s Core Laboratories CLB Stock Holding History

Huntington National Bank’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-256	Closed	-$3.84K	–	4166
2025 Q1	$3.84K	Sell	256 -92	-26%	-$1.54K	﹤0.01%	2056
2024 Q4	$6.02K	Hold	348	–	–	﹤0.01%	1936
2024 Q3	$6.45K	Hold	348	–	–	﹤0.01%	1916
2024 Q2	$7.06K	Sell	348 -49	-12%	-$867	﹤0.01%	1812
2024 Q1	$6.78K	Buy	397 +353	+802%	+$5.55K	﹤0.01%	1829
2023 Q4	$777	Buy	+44	New	+$887	﹤0.01%	2255
2023 Q1	–	Sell	-272	Closed	-$5.51K	–	3650
2022 Q4	$5.51K	Buy	272 +25	+10%	+$485	﹤0.01%	1621
2022 Q3	$3K	Buy	247 +29	+13%	+$489	﹤0.01%	1780
2022 Q2	$4K	Hold	218	–	–	﹤0.01%	1764
2022 Q1	$7K	Sell	218 -16	-7%	-$449	﹤0.01%	1676
2021 Q4	$5K	Hold	234	–	–	﹤0.01%	1718
2021 Q3	$6K	Buy	234 +69	+42%	+$2.1K	﹤0.01%	1543
2021 Q2	$6K	Hold	165	–	–	﹤0.01%	1526
2021 Q1	$5K	Buy	165 +3	+2%	+$102	﹤0.01%	1448
2020 Q4	$4K	Hold	162	–	–	﹤0.01%	1423
2020 Q3	$2K	Hold	162	–	–	﹤0.01%	1424
2020 Q2	$3K	Hold	162	–	–	﹤0.01%	1370
2020 Q1	$2K	Buy	162 +2	+1%	+$56	﹤0.01%	1431
2019 Q4	$6K	Hold	160	–	–	﹤0.01%	1473
2019 Q3	$7K	Buy	160 +116	+264%	+$5.39K	﹤0.01%	1323
2019 Q2	$2K	Buy	44 +31	+238%	+$1.82K	﹤0.01%	1497
2019 Q1	$0	Sell	13 -27	-68%	-$1.81K	﹤0.01%	1574
2018 Q4	$2K	Sell	40 -19	-32%	-$1.64K	﹤0.01%	1554
2018 Q3	$7K	Buy	+59	New	+$6.66K	﹤0.01%	1437
2018 Q2	–	Sell	-55	Closed	-$6K	–	1583
2018 Q1	$6K	Hold	55	–	–	﹤0.01%	1400
2017 Q4	$6K	Hold	55	–	–	﹤0.01%	1426
2017 Q3	$5K	Buy	55 +11	+25%	+$1.07K	﹤0.01%	1454
2017 Q2	$4K	Hold	44	–	–	﹤0.01%	1403
2017 Q1	$5K	Hold	44	–	–	﹤0.01%	1249
2016 Q4	$5K	Hold	44	–	–	﹤0.01%	1290
2016 Q3	$5K	Buy	+44	New	+$5.07K	﹤0.01%	1348
2016 Q2	–	Sell	-1,018	Closed	-$106K	–	1526
2016 Q1	$106K	Buy	+1,018	New	+$106K	﹤0.01%	885
2015 Q3	–	Sell	-1,018	Closed	-$116K	–	1732
2015 Q2	$116K	Hold	1,018	–	–	﹤0.01%	868
2015 Q1	$106K	Hold	1,018	–	–	﹤0.01%	890
2014 Q4	$123K	Buy	+1,018	New	+$134K	﹤0.01%	852
2014 Q2	–	Sell	-1,575	Closed	-$313K	–	1064
2014 Q1	$313K	Buy	1,575 +1,084	+221%	+$205K	0.01%	952
2013 Q4	$94K	Sell	491 -11	-2%	-$2.05K	﹤0.01%	919
2013 Q3	$85K	Buy	502 +16	+3%	+$2.48K	﹤0.01%	929
2013 Q2	$74K	Buy	+486	New	+$68.9K	﹤0.01%	950

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Huntington National Bank's CLB Position: Q2 2025 in Review

Huntington National Bank sold out of Core Laboratories (CLB) in Q2 2025, closing a stake of 256 shares — an estimated $3.84K sold.

Huntington National Bank first reported a position in CLB in Q2 2013 and held it in 39 quarters. The position peaked at $313K in Q1 2014. 191 funds tracked by Wall St. Rank hold CLB as of Q2 2025.

Huntington National Bank reported no remaining Core Laboratories position as of Q2 2025 after selling out during the quarter.
Huntington National Bank sold 256 Core Laboratories shares in Q2 2025, an estimated $3.84K.
Huntington National Bank first reported a position in Core Laboratories in Q2 2013 and held it in 39 quarters.
Huntington National Bank's Core Laboratories position peaked at $313K in Q1 2014.
191 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2025.

Based on Huntington National Bank's 13F filing for Q2 2025, filed 5 Aug 2025.